Research
Topics Publications In progress publications CommunicationsPackages
AnaQol Project PRO-online R Packages Online R-packageLife of the unit
Projects Collaborations PhD thesis Traineeships Traineeships propositions SeminarsNext seminars
Last publications
01 décembre 2020
17 novembre 2020
02 octobre 2020
02 septembre 2020
29 août 2020
Updated
17 décembre 2020Longitudinal associations between coping strategies, locus of control and health-related quality of life changes in patients with breast cancer or melanoma
Auteurs
- Toscano Anna - Doctorante en Psychologie de la Santé - Université de Turin - Université de Nantes
- Blanchin Myriam - Ingénieur de recherche en Biostatistique - Université de Nantes - UFR de Pharmacie
- Bourdon Marianne - Post-doctorante - Psychologie de la Santé - ICO
- Bonnaud-Antignac Angélique - Professeur des Universités - Responsable de l'Unité Fonctionnelle de Psycho-Oncologie de l'Institut de Cancérologie de l'Ouest Centre René Gauducheau - UFR de Médecine - Université de Nantes et Institut de Cancérologie de l'Ouest (ICO)
- Sébille Véronique - PU-PH Biostatistique - Directrice de l'unité SPHERE - Université de Nantes - UFR de Pharmacie
Description
Lien
Abstract
Purpose A diagnosis of breast cancer or melanoma is a traumatic life event that patients have to face. However, their locus-of-control (LOC) beliefs and coping strategies as well as the associations with health-related quality of life (HRQoL) changes over time are still not well known and rarely compared by cancer site. Methods The objective of this longitudinal study was to assess the association of LOC (Cancer Locus-of-Control Scale) and coping (Brief Cope) changes, with change in HRQoL (EORTC QLQ-C30) over time in newly diagnosed breast cancer and melanoma patients at 1, 6, 12, and 24 month post-diagnosis. Mixed models were used to compare LOC and coping longitudinal changes as well as their associations with HRQoL changes in early-stage breast cancer and melanoma patients. Results Overall, 215 breast cancer and 78 melanoma patients participated in the study. At baseline, HRQoL levels were often higher for breast cancer compared to melanoma patients. For breast cancer and melanoma patients, negative coping strategies and perceived control over the course of illness were negatively and positively associated with HRQoL changes, respectively. For breast cancer patients only, emotional coping and internal causal attribution were negatively associated with HRQoL changes. For both cancer sites, living with a partner correlated with worse HRQoL. Conclusions Understanding coping strategies and LOC beliefs used by patients soon after their cancer diagnosis and over the course of illness can help identifying psychological and supportive care to modify maladaptive thoughts and beliefs and promote more adaptive behaviors to ultimately improve patients’ well-being and HRQoL.
Projet(s) ayant donné lieu à cette publication
Thèse(s) ou stage(s) lié(s) à cette publication
Publications ayant le même axe principal de recherche (Utilisation pratique des Mesures Subjectives en Santé)
Enjalbert L ,Hardouin JB ,Blanchin M ,Giral M ,Morelon E ,Cassuto E ,Meurette A ,Sébille V (2020) Comparison of longitudinal quality of life outcomes in preemptive and dialyzed patients on waiting list for kidney transplantation. Quality of Life Research, 29(4): 959-970.Meurisse V ,Tauveron V ,Tavernier E ,Vignes S ,Geremia S ,Leducq S ,Vaillant L ,Maruani A (2020) Sport Activities and Exercise in Individuals With Lymphedema: A French National Survey on Practices and Fears . Eur J Dermatol, 30(1): 63-6.Bulteau S ,Sauvaget A ,Vanier A ,Vanelle J ,Poulet E ,Brunelin J ,Sébille V (2019) Depression Reappraisal and Treatment Effect: Will Response Shift Help Improve the Estimation of Treatment Efficacy in Trials for Mood Disorders?. Front Psychiatry, 10: 420.Forestier B ,Anthoine E ,Reguiai Z ,Fohrer C ,Blanchin M (2019) A systematic review of dimensions evaluating patient experience in chronic illness. Health and Quality of Life Outcomes, 17(1): 19.Le Sache de Peufheiloux L ,Benamara-Lévy M ,Dionne M ,Bodemer C ,Leducq S ,Samimi M ,Maruani A (2018) Treatments and outcomes in juvenile linear scleroderma: a narrative systematic review. Eur J Dermatol, 28(5): 718-20.-
Blanchin M ,Hardouin JB ,Bonnaud-Antignac A ,Sébille V (2016) Analysis of longitudinal patient reported outcomes data with Classical Test Theory and Rasch-based methods: an application on health-related quality of life in breast cancer patients. Statistica Applicata – Italian Journal of Applied Statistics, 27(1): 41-56. Ali A ,Carré A ,Hassler C ,Spilka S ,Vanier A ,Barry C ,Berthoz S (2016) Risk factors for substances use and misuse among young people in France: What can we learn from the Substance Use Risk Profile Scale?. Drug and Alcohol Dependence, 163: 84-91.-
Brédart A ,Merdy O ,Sigal-Zafrani B ,Fiszer C ,Dolbeault S ,Hardouin JB (2016) Identifying trajectory clusters in breast cancer survivors' supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later.. Supportive Care in Cancer, 24(1): 357-366. Anthoine E ,Coutherut J ,Delmas C ,Moret L (2014) Facilitators and barriers of interprofessional collaboration regarding of perceived practices of sharing medical information and team communication. Journal of Interprofessional Care: .Moret L ,Anthoine E ,Gillet N ,Fouquereau E ,Colombat P (2013) Organisation du travail, démarche participative et satisfaction des patients hospitalisés : une évaluation dans 47 services d’oncohématologie. Psycho-Oncol, 8(3): 157-164.-
Hardouin JB ,Audureau E ,Leplège A ,Coste J (2012) Spatio-temporal Rasch analysis of Quality of life outcomes in the french general population. Measurement invariance and group comparisons . BMC Medical Research Methodology, 12: 182. Omnes C ,Hardouin JB (2004) Belote et rebelote, comment éviter le dix de der ? (Suicide attempts : can we predict the recurrence ?). Revue française de psychiatrie et de psychologie médicale: 27-32.
Publications liées à l'axe principal de recherche (Utilisation pratique des Mesures Subjectives en Santé)
Robert J ,Tavernier E ,Boccara O ,Mashiah J ,Mazereeuw-Hautier J ,Maruani A (2020) Modalities of Use of Oral Propranolol in Proliferative Infantile Haemangiomas: An International Survey Among Practitioners. Br J Dermatol: doi: 10.1111/bjd.19047. Online ahead of print..Bourdon M ,Blanchin M ,Campone M ,Quéreux G ,Dravet F ,Sébille V ,Bonnaud-Antignac A (2019) A comparison of post-traumatic growth changes in breast cancer and melanoma. Health psychology, 38(10): 878-887.-
Hamel JF ,Sébille V ,Le Neel T ,Kubis G ,Boyer F ,Hardouin JB (2017) What are the appropriate methods for analyzing patients reported outcomes in randomized trials when data are missing?. Statistical Methods in Medical Research, 26(6): 2897-2908. Salmon M ,Blanchin M ,Rotonda C ,Guillemin F ,Sébille V (2017) Identifying patterns of adaptation in breast cancer patients with cancer-related fatigue using response shift analyses at subgroup level. Cancer Medicine, 6(11): 2562-2575.-
de Bock E ,Hardouin JB ,Blanchin M ,Le Neel T ,Kubis G ,Dantan E ,Bonnaud-Antignac A ,Sébille V (2016) Rasch-family models are more valuable than score-based approaches for analysing longitudinal PRO with intermittent missing data. Statistical Methods in Medical Research , 25(5): 2067–2087. (Soumis) Blanchin M ,Hardouin JB ,Le Neel T ,Kubis G ,Sébille V (2016) CTT and Rasch-based approaches for joint analysis of group and time effects of longitudinal Patient Reported Outcomes: impact of dropout mechanisms..Bonnaud-Antignac A ,Tessier P ,Nazih F ,Quere M ,Sébille V ,Hardouin JB (2015) Stress, Qualité de vie et Santé des étudiants Suivi de cohortes en Première Année Commune d’Etude en Santé (PACES). Jounal de thérapie cognitive et comportementale: in press.-
Blanchard C ,Mathonnet M ,Sebag F ,Caillard C ,Kubis C ,Drui D ,Van der Nuvel E ,Ansquer C ,Henry JF ,Masson D ,Kraeber-Bodéré F ,Hardouin JB ,zarnegar R ,Hamy A ,Mirallié E (2014) Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively Results of a prospective multicenter study. Annals of Surgical Oncology, 21(11): 3534-3540. Rat C ,Quéreux G ,Monnier A ,Gautier J ,Bonnaud-Antignac A ,Khammari A ,Dréno B ,N'guyen S , Monegier du Sorbier M , Gaultier A (2014) Patients at elevated risk of melanoma: Individual predictors of non-compliance to GP referral for a dermatologist consultation. Preventive Medicine, 64: 48-53.-
Rouquette A ,Blanchin M ,Sébille V ,Guillemin F ,Côté SM ,Falissard B ,Hardouin JB (2014) Determination of the Minimal Clinically Important Difference using Item Response Theory Models: an attempt to solve the issue of the association with baseline score. Journal of Clinical Epidemiology, 64(4): 433-440. -
Clermidi P ,Podevin G ,Crétolle C ,Sarnacki S ,Hardouin JB (2013) The challenge of measuring quality of life for children with Hirschsprung's diseases or anorectal malformations. Journal of Pediatric Surgery, 48(10): 2118-2127. -
Hamel JF ,Hardouin JB ,Le Neel T ,Kubis G ,Roquelaure Y ,Sébille V (2012) Study of different methods for comparing groups by analysis of subjective health measurements. PLoS One, 7(10): e44695. -
Bonnaud-Antignac A ,Hardouin JB ,Léger J ,Dravet F ,Sébille V (2012) Quality of life and coping of women treated for breast cancer and their caregivers. What are the interactions?. Journal of Clinical Psychology in Medical Settings, 19: 320-328. Dely C ,Sellier P ,Dozol A ,Segouin C ,Moret L ,Lombrail P (2012) Preventable readmissions of "community-acquired pneumonia": Usefulness and reliability of an indicator of the quality of care of patients' care pathways.. Presse Med, 9(1): 51-7.Blanchin M (2011) Comparaison des approches CTT et IRT pour l'analyse des effets temps et groupe de données longitudinales de type Patient-Reported Outcomes et impact du dropout. Thèse de doctorat de l'Université de Nantes - Ecole doctorale Biologie Santé, 219 pages.Lelorain S ,Tessier P ,Florin A ,Bonnaud-Antignac A (2011) Predicting Mental Quality of Life in Breast Cancer Survivors Using Comparison Participants. Journal of Psychosocial Oncology, 29(4): 430-449.